Gut microbiota and drug metabolism: the forgotten organ

Read full text Summarise with VIRAT
Authors: {"name":"Kamatham Udayasri","email":"udayasrikamatham@gmail.com","affiliation", {"name":"Achutha Giridhar","email":"udayasrikamatham@gmail.com","affiliation", {"name":"Yadala Prapurna Chandra","email":"udayasrikamatham@gmail.com","affi
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

The human gut microbiota, often termed the “forgotten organ,” plays a pivotal role in xenobiotic metabolism and significantly influences drug disposition, efficacy, and safety. While traditional pharmacokinetics and pharmacodynamics have emphasized hepatic and renal pathways, growing evidence shows that gut microbial enzymes can modify drug structures, alter absorption, and generate toxic metabolites. This review examines the mechanisms by which intestinal microbes metabolize therapeutic agents, highlightin g examples across major drug classes and outlining the clinical implications of microbiota – drug interactions. It also considers factors that modulate microbial activity — including diet, antibiotics, probiotics, and disease states — and how these variables aff ect pharmacokinetic parameters and therapeutic outcomes. Gut microbes perform diverse biotransformations such as reduction, hydrolysis, deconjugation, and methylation via enzymes including β - glucuronidase, azoreductase, and nitroreductase. These reactions may activate or inactivate drugs, thereby altering plasma concentrations, bioavailability, and adverse effect profiles. Clinical examples, such as the interaction between Eggerthella lenta and digoxin and β - glucuronidase – mediated irinotecan toxicity, demon strate the impact of microbiota variability on patient response. Integrating microbiome science with pharmacogenomics may advance personalized medicine and improve therapeutic safety.

Fields of Study & Subjects

Pharmacogenetics and Drug Metabolism Gut microbiota and health Drug Transport and Resistance Mechanisms

Publication details

Journal / source
International Journal of Experimental and Biomedical Research
Volume
5
Issue
1
Pages
17–33
Publication date
6 January 2026
Language
EN